Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27kip1 and p21cip1

被引:51
作者
Bagui, TK
Jackson, RJ
Agrawal, D
Pledger, WJ
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Dept Oncol, Tampa, FL USA
[3] Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA
关键词
D O I
10.1128/MCB.20.23.8748-8757.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our studies examined the effects of p27(kip1) and p21(cip1) on the assembly and activity of cyclin D3-cdk4 complexes and determined the composition of the cyclin D3 pool in cells containing and lacking these cyclin-dependent kinase inhibitors. We found that catalytically active cyclin D3-cdk4 complexes were present in fibroblasts derived from p27(kip1)-p21(cip1)-null mice and that immunodepletion of extracts of wild-type cells dth antibody to p27(kip1) and/or p21(cip1) removed cyclin D3 protein but not cyclin D3 associated activity. Similar results were observed in experiments assaying cyclin D1-cdk4 activity. Data obtained using mixed cell extracts demonstrated that p27(kip1) interacted with cyclin D3-cdk4 complexes in vitro and that this interaction was paralleled by a loss of cyclin D3-cdk4 activity. In p27(kip1)-p21(cip1)-deficient cells, the cyclin D3 pool consisted primarily of cyclin D3 monomers, whereas in mild-type cells, the majority of cyclin D3 molecules were complexed to cdk4 and either p27(kip1) or p21(cip1) or were monomeric. We conclude that neither p27(kip1) nor p21(cip1) is required for the formation of cyclin D3-cdk4 complexes and that cyclin D3-cdk4 complexes containing p27(kip1) or p21(cip1) are inactive. We suggest that only a minor portion of the total cyclin D3 pool accounts for all of the cyclin D3-cdk4 activity in the cell regardless of whether the cell contains p27(kip1) and p21(cip1).
引用
收藏
页码:8748 / 8757
页数:10
相关论文
共 52 条
  • [1] Agrawal D, 1996, MOL CELL BIOL, V16, P4327
  • [2] The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity
    Alessi, F
    Quarta, S
    Savio, M
    Riva, F
    Rossi, L
    Stivala, LA
    Scovassi, AI
    Meijer, L
    Prosperi, E
    [J]. EXPERIMENTAL CELL RESEARCH, 1998, 245 (01) : 8 - 18
  • [3] Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-Cdk2 and cyclin D2-Cdk4
    Blain, SW
    Montalvo, E
    Massague, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) : 25863 - 25872
  • [4] RADIATION-INDUCED CELL-CYCLE ARREST COMPROMISED BY P21 DEFICIENCY
    BRUGAROLAS, J
    CHANDRASEKARAN, C
    GORDON, JI
    BEACH, D
    JACKS, T
    HANNON, GJ
    [J]. NATURE, 1995, 377 (6549) : 552 - 557
  • [5] Carlson BA, 1996, CANCER RES, V56, P2973
  • [6] THE E2F TRANSCRIPTION FACTOR IS A CELLULAR TARGET FOR THE RB PROTEIN
    CHELLAPPAN, SP
    HIEBERT, S
    MUDRYJ, M
    HOROWITZ, JM
    NEVINS, JR
    [J]. CELL, 1991, 65 (06) : 1053 - 1061
  • [7] The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
    Cheng, MG
    Olivier, P
    Diehl, JA
    Fero, M
    Roussel, MF
    Roberts, JM
    Sherr, CJ
    [J]. EMBO JOURNAL, 1999, 18 (06) : 1571 - 1583
  • [8] Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
    Cheng, MG
    Sexl, V
    Sherr, CJ
    Roussel, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) : 1091 - 1096
  • [9] Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle
    Coats, S
    Flanagan, WM
    Nourse, J
    Roberts, JM
    [J]. SCIENCE, 1996, 272 (5263) : 877 - 880
  • [10] A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells
    Coats, S
    Whyte, P
    Fero, ML
    Lacy, S
    Chung, G
    Randel, E
    Firpo, E
    Roberts, JM
    [J]. CURRENT BIOLOGY, 1999, 9 (04) : 163 - 173